Vapotherm, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Vapotherm, Inc. develops and commercializes advanced non-invasive respiratory support technologies, specializing in high velocity therapy (HVT) for patients experiencing respiratory distress across neonates, pediatrics and adults; its core products include the HVT 2.0 system for pediatrics-to-adults with integrated blower, touchscreen interface, nurse call and EMR connectivity; Precision Flow Hi-VNI system for neonates delivering mask-free humidified high-flow nasal insufflation; Unicorn Cannula with advanced CO2 flush capabilities; Precision Flow Heliox; disposable patient circuits, capital and disposable accessories; and the Oxygen Assist Module available in select international markets. The company, founded in 1999 and headquartered in Exeter, New Hampshire, operates globally in over 40 countries with manufacturing in New Hampshire and Mexico, targeting hospitals, emergency departments, ICUs, NICUs and EMS for conditions such as COPD, pneumonia, heart failure, asthma and COVID-19-related distress. In June 2024, Vapotherm entered a definitive merger agreement with a Perceptive Advisors-backed entity, culminating in the company's privatization in September 2024 through a $2.18-per-share cash deal, accompanied by SLR Capital Partners converting $81-83 million of debt to preferred equity and Perceptive investing $50 million in new capital while retaining $40 million in term debt; recent developments include a September 2024 partnership with Onymos for an IoMT digital platform, May 2025 confirmation of Unicorn Cannula efficacy at lower flow rates, and a technology roadmap featuring HVT Home, VapoCloud and VTAccess 365 for 2025-2026 home and digital expansions.
Vapotherm Announces Closing of Merger
Vapotherm Reports Second Quarter 2024 Financial Results
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. - VAPO
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. – VAPO
The Schall Law Firm Is Performing A Scrutiny Into Vapotherm Inc And Welcomes Investors Of VAPO To Engage
The Schall Law Firm Is Carrying Out An Inquiry Into Vapotherm Inc And Requests Investors Of VAPO To Be Part Of It
The Schall Law Firm Is Undertaking An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join
The Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join
The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages VAPO Investors To Participate
The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages Investors Of VAPO To Participate
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, VAPO on Behalf of Shareholders
The Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites VAPO Investors To Join
Vapotherm Inc Investigation Conducted By Schall Law Firm Invites Participation From Investors In VAPO
An Investigation Into Vapotherm Inc Is Being Carried Out By The Schall Law Firm And VAPO Shareholders Can Join
The Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Shareholders Of VAPO Are Invited To Participate
VAPO Shareholders Have The Opportunity To Be Involved In The Vapotherm Inc Probe Led By The Schall Law Firm
Biggest Penny Stock Winners in June
Shareholders Of VAPO Can Participate In The Examination Of Vapotherm Inc Conducted By The Schall Law Firm
VAPOTHERM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vapotherm, Inc. - VAPO
Investors Of VAPO Have The Opportunity To Join The Vapotherm Inc Probe Led By The Schall Law Firm